OrbiMed’s Medpace MEDP Stock Holding History

OrbiMed’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-44,900	Closed	-$14.9M	–	118
2024 Q4	$14.9M	Hold	44,900	–	–	0.31%	61
2024 Q3	$15M	Buy	+44,900	New	+$17.1M	0.27%	72

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

OrbiMed's MEDP Position: Q1 2025 in Review

OrbiMed sold out of Medpace (MEDP) in Q1 2025, closing a stake of 44,900 shares — an estimated $14.9M sold.

OrbiMed first reported a position in MEDP in Q3 2024 and held it in 2 quarters. The position peaked at $15M in Q3 2024. 586 funds tracked by Wall St. Rank hold MEDP as of Q1 2025.

OrbiMed reported no remaining Medpace position as of Q1 2025 after selling out during the quarter.
OrbiMed sold 44,900 Medpace shares in Q1 2025, an estimated $14.9M.
OrbiMed first reported a position in Medpace in Q3 2024 and held it in 2 quarters.
OrbiMed's Medpace position peaked at $15M in Q3 2024.
586 funds tracked by Wall St. Rank held Medpace as of Q1 2025.

Based on OrbiMed's 13F filing for Q1 2025, filed 15 May 2025.